What are we lobbying for?
Some of the most exciting research JDRF is doing globally is happening right here in Canada thanks to the JDRF Canadian Clinicial Trial Network (JDRF CCTN). Here are just a few of the leading edge trials we’ve funded:
- ViaCyte’s encapsulation trial which aims to introduce insulin-producing cells into the body by means of a permeable device which protects them from immune attack. This trial could help people with type 1 diabetes (T1D) avoid dangerous blood sugar highs and lows without the need to monitor blood sugar levels or inject insulin for up to 24 months at a time;
- CONCEPTT’s maternal health study which is looking at the benefit of using a continuous glucose monitor (CGM) during pregnancy to improve maternal health outcomes for mother and child;
- The Transition Trial is studying ways to improve diabetes management among adolescents aged 18-24, in the hopes of reducing severe incidents of hyper- and hypo-glycemia that still claim too many young lives. Another seeks to prevent the devastating complications, including vision loss, nerve damage and kidney disease, associated with diabetes (Type 1 and Type 2.)
- The Artificial Pancreas Standards and Technical Platform Project is piloting the development of standard communications protocols for insulin pumps, blood glucose meters, continuous glucose monitors and personal smart phones in the hopes of improving interoperability and accelerating development of artificial pancreas systems.
Find out more about JDRF CCTN.